Kaede Hiruma, Masayuki Tasaki, Tsutomu Anraku, Masahiro Ikeda, Kazuhide Saito, Yoshifumi Shimada, Yoshihiko Tomita. A Case of Giant Neobladder Stone of 5 Kg. IJU case reports. 2025. 8. 3. 281-284
Tsutomu Anraku, Masaki Murata, Hiroo Kuroki, Akira Kazama, Yuko Shirono, Masayuki Tasaki, Vladimir Bilim, Yoshihiko Tomita. Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma. Journal of personalized medicine. 2024. 14. 7
Yuko Shirono, Vladimir Bilim, Tsutomu Anraku, Hiroo Kuroki, Akira Kazama, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita. Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells. Current oncology (Toronto, Ont.). 2023. 30. 6. 5350-5365
Tsutomu Anraku, Hideki Hashidate, Asa Nakahara, Tomoyuki Imai, Yoshiaki Kawakami. Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy. BMC urology. 2023. 23. 1. 38-38
Akira Kazama, Vladimir Bilim, Masayuki Tasaki, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita. Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma. Scientific reports. 2022. 12. 1. 20386-20386
